Clovis Oncology, Inc. Shareholders' Equity
Clovis Oncology, Inc. had Shareholders' Equity of -$417.89 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-09
- 2022-09-30: Stockholders' Equity Attributable to Parent -$417.89M.
- 2022-06-30: Stockholders' Equity Attributable to Parent -$367.69M.
- 2022-03-31: Stockholders' Equity Attributable to Parent -$303.31M.
- 2021-12-31: Stockholders' Equity Attributable to Parent -$278.84M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2022-09-30 | -$417.89M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$367.69M 10-Q · filed 2022-11-09 | |
| 2022-03-31 | -$303.31M 10-Q · filed 2022-11-09 | |
| 2021-12-31 | -$278.84M 10-Q · filed 2022-11-09 | |
| 2021-09-30 | -$225.46M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$206.98M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | -$221.04M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | -$158.75M 10-Q · filed 2022-11-09 | |
| 2020-09-30 | -$163.37M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | -$97.38M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | -$126.99M 10-Q · filed 2021-11-03 | -$126.99M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$174.26M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$87.50M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$29.98M 10-Q · filed 2020-11-05 | -$29.98M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $74.85M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $146.47M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $233.67M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $312.35M 10-Q · filed 2019-11-07 | $312.35M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $306.24M 10-Q · filed 2019-11-07 | $306.24M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $367.63M 10-K · filed 2021-02-25 | $367.64M 10-K · filed 2018-02-27 |
| 2017-09-30 | $299.19M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $343.79M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $174.21M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$3.63M 10-K · filed 2020-02-26 | -$3.63M 10-K · filed 2017-02-23 |
| 2016-09-30 | $57.04M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $112.83M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $232.66M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $300.65M 10-K · filed 2019-02-28 | |
| 2015-09-30 | $414.32M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $199.67M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $252.59M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $331.63M 10-K · filed 2018-02-27 | |
| 2014-09-30 | $388.29M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $441.61M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $472.74M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $497.89M 10-K · filed 2017-02-23 | |
| 2013-09-30 | $345.53M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $363.00M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $119.74M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $133.50M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $152.88M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $169.57M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $113.98M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $131.79M 10-K · filed 2015-02-27 | |
| 2010-12-31 | -$54.75M 10-K · filed 2014-02-28 | |
| 2009-12-31 | -$17.06M 10-K · filed 2014-02-28 |